Nathan Berman communicating with investors over Pfizer project

While shoring up the former Pfizer headquarters in Midtown East, its developer is also looking to shore up investor support. MetroLoft’s Nathan Berman has been talking to investors of the office-to-residential project since Tuesday’s incident, the New York Times reported. Berman’s ability to meet the construction timeline relies not just on the ability to resume work at 235 East 42nd Street, but to hold on to his financing. Berman told investors that there would be relatively minor delays, but that the project would be completed next year, as intended. Berman has said he only expects the delay to last a […]

This article originally appeared on The Real Deal. Click here to read the full story.